A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials Comparing Robotic Assisted Cancer Surgery with the Laparoscopic or Open Approach

Author(s)

Hebert A1, Yankovsky A2, Patel N2, Kreaden U3
1Intuitive Surgical, San Marcos, CA, USA, 2Intuitive Surgical, Palo Alto, CA, USA, 3Intuitive Surgical, Sunnyvale, CA, USA

Presentation Documents

OBJECTIVES: Randomized controlled trials (RCT) are the “Gold standard” for assessing medical devices; however, there is a paucity of RCTs and typical hospital programs offer multispecialty robotic surgery. Therefore, we compared a set of common clinical outcomes for robotic, laparoscopic, and open surgery across multiple specialties.

METHODS: A systematic literature review (using PRISMA) and meta-analysis (using RevMan 5.4) was performed. Randomized controlled trials involving robotic surgery performed with da Vinci Surgical systems published in PubMed, Embase, and Scopus from January 1, 2010 to August 4, 2022 were included. Exclusion criteria were language not English, pediatric population, benign procedures, no outcomes of interest, or redundant data. Primary outcomes were operative time, conversions, transfusions, length of hospital stay, postoperative complications, reoperations, readmission, and mortality within 30-days (Prospero #CRD42022374854).

RESULTS: The search identified 44 RCTs across urology, gynecology, colorectal, thoracic, general surgery, and head & neck specialties for cancer indications. Compared to open surgery, robotic-assisted surgery resulted in fewer transfusions (OR 0.41 [0.29, 0.57], p<0.00001) and postoperative complications (OR 0.60 [0.44, 0.80], p=0.0006), and a shorter hospital stay (WMD -1.00 [-1.65, -0.35], p=0.003). Compared to laparoscopic surgery, robotic-assisted surgery resulted in fewer conversions (RD -0.0123 [-0.0245, -0.0001, p=0.049) and a shorter hospital stay (WMD -0.57 [-0.92, -0.21], p=0.002). There were no differences in transfusions or postoperative complications. Operative time was significant in favor of laparoscopic (WMD 27.76 [15.92, 39.60], p<0.00001) and open (WMD 56.94 [36.48, 77.39], p<0.00001) surgery. There was no difference in readmission, reoperation, or mortality for either comparison.

CONCLUSIONS: Our meta-analysis of available RCTs using the da Vinci surgical systems for cancer procedures has shown similar or superior surgical outcomes for robotic assisted surgery compared to open or laparoscopic surgery across 6 specialties. These findings can help policy makers and healthcare providers evaluate robotic-assisted surgery from a multispecialty perspective.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

MT44

Topic

Clinical Outcomes, Medical Technologies

Topic Subcategory

Clinical Outcomes Assessment, Medical Devices

Disease

Oncology, Surgery

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×